CD4 and Granuloma: To study the effect of IDO inhibition on the dynamics of different T cell types in granulomas at endpoint, multilabel IHC was performed on lung sections (containing granulomas) obtained from D1MT+cART-treated and cART-only treated RMs for CD4, CD8, IDO1, and CD68 (pan macrophage marker).